up up and awayHuzzah... CRSP up to 90 bucks a share... always worth backing the best in class company. Now heading towards a three bagger now w Azzak. Sad that the only value ONCY seems to have is in tax loss harvesting... LOL... what a company...!!
with respect to ONCY's management, perhaps if the C-suite were not so greedy and aligned their compensation with that of the shareholders, they would have a little more incentive to progress things, and we'd be in a few Phase III trials already.
Compare Coffey et al. with Marcus Lemonis of Bed, Bath and Beyond (BYON, formerly Overstock), He's not taking a penny until the stock reaches $45, currently $27, and will get another payout at $60.
Now that is a leader one can respect and have confidence in... Not the Homer Simpson lookalike we have at the healm of ONCY.. For those who have held a position in this p os for as long as me, you will know that management stating that results are delayed because patients are living longer and longer, is exactly the language used during ONCY's failed Phase III trial for H&N cancer... How sad that they seemed to have learned nothing...